Mariner, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Mariner, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$1,856,019
-25.1%
49,179
-9.6%
0.01%
-28.6%
Q2 2023$2,478,522
+112713.9%
54,412
+0.4%
0.01%
+16.7%
Q1 2023$2,197
-61.1%
54,198
-51.1%
0.01%
-66.7%
Q4 2022$5,652
-99.9%
110,900
-3.6%
0.02%
-28.0%
Q3 2022$6,194,000
-8.6%
115,007
+8.9%
0.02%
-10.7%
Q2 2022$6,780,000
-0.7%
105,567
+19.9%
0.03%
+7.7%
Q1 2022$6,829,000
+14.9%
88,069
+27.2%
0.03%
+4.0%
Q4 2021$5,944,000
+26.9%
69,250
+18.9%
0.02%
+4.2%
Q3 2021$4,684,000
+17.1%
58,242
+17.2%
0.02%
-4.0%
Q2 2021$4,000,000
+11.5%
49,694
+16.9%
0.02%0.0%
Q1 2021$3,586,000
+70.8%
42,522
+62.5%
0.02%
+56.2%
Q4 2020$2,100,000
+82.5%
26,168
+82.8%
0.02%
+45.5%
Q3 2020$1,151,000
-1.7%
14,315
+5.2%
0.01%
-8.3%
Q2 2020$1,171,000
+14.6%
13,602
+8.0%
0.01%
-7.7%
Q1 2020$1,022,000
-7.9%
12,590
-5.1%
0.01%
+8.3%
Q4 2019$1,110,000
-12.5%
13,269
-8.5%
0.01%
-20.0%
Q3 2019$1,268,000
+35.9%
14,499
+27.3%
0.02%
+36.4%
Q2 2019$933,000
+4.1%
11,387
+3.3%
0.01%
-15.4%
Q1 2019$896,000
-69.4%
11,021
-75.2%
0.01%
-75.0%
Q4 2018$2,929,000
+392.3%
44,493
+476.2%
0.05%
+246.7%
Q3 2018$595,000
+15.3%
7,722
+10.4%
0.02%0.0%
Q2 2018$516,000
+42.5%
6,992
+25.7%
0.02%
+15.4%
Q1 2018$362,000
+40.3%
5,563
+39.1%
0.01%
+30.0%
Q4 2017$258,000
+25.9%
3,999
+22.6%
0.01%
+11.1%
Q3 2017$205,000
-17.3%
3,263
-8.0%
0.01%
-18.2%
Q2 2015$248,000
+14.3%
3,546
+19.6%
0.01%
-45.0%
Q4 2014$217,0002,9640.02%
Other shareholders
BAXTER INTL INC shareholders Q4 2021
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders